Search
01/08/2024
Exploring Plasma Coenzyme Q10 Status in Paediatric Dyslipidaemia
Minguez, B, de Los Santos, M, Garcia-Volpe, C, Molera, C, Paredes-Fuentes, AJ, Oliva, C, Arias, A, Rodriguez-Gonzalez, H, Yubero, D, Tondo, M, Santos-Ocaña, C, Meavilla, S, Artuch, R. Exploring Plasma Coenzyme Q10 Status in Paediatric Dyslipidaemia. Antioxidants. 2024; 13(8)DOI:10.3390/antiox13080966. PMID:39199213. IF:6.600(Q1/1D).
01/05/2026
Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study
Garcia-Pagan, JC, Gluud, LL, Mandorfer, M, Schattenberg, JM, De Gottardi, A, Berzigotti, A, Fortea, JI, Martínez, AA, Alvarado-Tapias, E, Berning, M, Petryszyn, P, Henricson, E, Berglind, N, Lin, M, Persson, K, Mercier, A, Ambery, P, Bosch, J, Oscarsson, J, Rockey, DC. Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; 92(5)DOI:10.1002/bcp.70332. PMID:41362018. IF:3.000(Q2/4D).
01/04/2026
Trends in incidence, prevalence, and survival of primary liver cancer in the United Kingdom (2000-2021)
Cuyàs, B, Alvarado-Tapias, E, Tan, EH, Golozar, A, Duarte-Salles, T, Delmestri, A, Argemi, J, Man, WY, Burn, E, Guarner-Argente, C, Alhambra, DP, Newby, D. Trends in incidence, prevalence, and survival of primary liver cancer in the United Kingdom (2000-2021). EUROPEAN JOURNAL OF PUBLIC HEALTH. 2026; 36(2)DOI:10.1093/eurpub/ckaf153. PMID:41212072. IF:3.900(Q1/2D).
01/11/2024
Strategies for the prevention and non-pharmacological treatment of obesity. Models of care
Rosales, A, Mendoza, L, Minambres, I. Strategies for the prevention and non-pharmacological treatment of obesity. Models of care. Atencion Primaria. 2024; 56(11)DOI:10.1016/j.aprim.2024.102978. PMID:38820670. IF:1.600(Q2/4D).
01/08/2025
Characterizing the clinical profile and prevalence of people with diabetes attended in the hospital setting by using unstructured healthcare data and natural language processing: the Diabetic@ study
Blanco-Carrasco, AJ, Merino-Torres, JF, Almanza, MR, Molina, GC, Brito-Sanfiel, MA, Galindo, DEB, Olmedo, LAC, Mauricio, D, Povedano, ST, Barro, JAB, Sánchez, JJA, Mutiozabal, MS, Pimentel, B, Domínguez, AP, Arias-Cabrales, C, Fanjul, V, de Isla, LP, González, JFN. Characterizing the clinical profile and prevalence of people with diabetes attended in the hospital setting by using unstructured healthcare data and natural language processing: the Diabetic@ study. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025; 226DOI:10.1016/j.diabres.2025.112214. PMID:40319920. IF:7.400(Q1/1D).
01/01/2026
Implementation of a Personalized Medicine Approach in Patients With Type 2 Diabetes Mellitus Receiving Multiple Daily Insulin Injections (POMA Project): Protocol for a Before-and-After Intervention Study (vol 15, e95267, 2026)
Giné-Balcells, R, Vlacho, B, Vidal-Pérez, OC, Lecub, A, Franch-Nadal, J, Mauricio, D, Molló-Iniesta, A, Hernández, M. Implementation of a Personalized Medicine Approach in Patients With Type 2 Diabetes Mellitus Receiving Multiple Daily Insulin Injections (POMA Project): Protocol for a Before-and-After Intervention Study (vol 15, e95267, 2026). Jmir Research Protocols. 2026; 15DOI:10.2196/95267. PMID:. IF:(Q/D).